Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ciǧdem Akalin Akkök"'
Autor:
Jagjit Singh Bhamra, Per Ole Iversen, Thomas Kjenner Titze, Geir Erland Tjønnfjord, Çiğdem Akalın Akkök
Publikováno v:
Case Reports in Hematology, Vol 2018 (2018)
Posttransfusion purpura is a serious adverse effect of transfusion due to HPA-antibodies. A young female was diagnosed with acute leukaemia, and treatment commenced. Severe thrombocytopenia ensued. No platelet increment was achieved despite transfusi
Externí odkaz:
https://doaj.org/article/08290d78b91a45afbd93d5f75136537f
Autor:
Guro Kristin Melve, Elisabeth Ersvaer, Çiğdem Akalın Akkök, Aymen Bushra Ahmed, Einar K. Kristoffersen, Tor Hervig, Øystein Bruserud
Publikováno v:
International Journal of Molecular Sciences, Vol 17, Iss 7, p 1158 (2016)
Peripheral blood stem cells from healthy donors mobilized by granulocyte colony-stimulating factor (G-CSF) and harvested by leukapheresis are commonly used for allogeneic stem cell transplantation. The frequency of severe graft versus host disease is
Externí odkaz:
https://doaj.org/article/cc6fda71c34546a6b43fd2166d76c12e
Autor:
Arne Kolstad, Peter Gaustad, Halvor Rollag, Ciǧdem Akalin Akkök, Pål Andre Holme, Yngvar Fløisand, Stein Bergan, D. Heldal, Tobias Gedde-Dahl, Gunnar Kvalheim, Dag Josefsen, Magnus Andreas Rognlien Husøy, Lorentz Brinch, Geir E. Tjønnfjord, Torstein Egeland, I. Dybedal
Publikováno v:
Tidsskrift for Den norske legeforening. 134:1569-1575
BACKGROUND Allogeneic stem cell transplantation (ASCT) has been a treatment option for patients with serious diseases of the blood and haematopoietic organs in Norway since 1985. Such treatment is potentially curative for selected patients who have a
Publikováno v:
Vox Sanguinis. 93:42-48
Background and Objectives Therapeutic or prophylactic use of platelet concentrates (PC) is essential for patients with thrombocytopenia due to intensive chemotherapy for various malignancies. PC quality has been improved after introduction of storage